Disease Management Program for the Care of Hypertensive Patients Using Telemedical Support: Under the Patronage of the Austrian Society of Hypertension

Background
Hypertension (HTN) is the leading global risk factor for premature death and disability. In Austria, as in many countries, treatment and blood pressure (BP) control rates are suboptimal. Previous studies have revealed low target achievement rates, emphasizing the need for innovative care models. Disease management programs (DMPs), particularly when supported by telemedicine, offer structured, coordinated approaches that can enhance care, adherence, and outcomes.

Objective
This position paper outlines the rationale, structure, and implementation considerations for a telemedicine-supported DMP for hypertensive patients in Austria. It aims to define inclusion criteria, technological infrastructure, creation of a health professional network, recruitment strategies, and expected outcomes to guide future deployment. The paper synthesizes existing epidemiological data from Austrian and international sources, reviews evidence from comparable telemedical interventions (e.g., the HERB system in Japan, HerzMobil in Austria), and integrates perspectives from healthcare providers and social security organizations. It proposes a model combining home-based BP monitoring, digital tools, and interdisciplinary support through a centralized coordination center. Existing Austrian telehealth platforms have successfully implemented similar models in heart failure and diabetes care. A pilot in Tyrol (HerzMobil HTN) showed improved control of hypertension.

Conclusion
A nationwide DMP for HTN in Austria leveraging telemedical tools is both feasible and urgently needed. Key success factors include clear inclusion criteria, technology access, comprehensive training, multidisciplinary collaboration, and patient recruitment strategies. Such a program promises improved BP control, reduced cardiovascular events, and long-term healthcare cost savings.